JP2024510939A5 - - Google Patents

Info

Publication number
JP2024510939A5
JP2024510939A5 JP2023553301A JP2023553301A JP2024510939A5 JP 2024510939 A5 JP2024510939 A5 JP 2024510939A5 JP 2023553301 A JP2023553301 A JP 2023553301A JP 2023553301 A JP2023553301 A JP 2023553301A JP 2024510939 A5 JP2024510939 A5 JP 2024510939A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
alkyl
compound according
regulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023553301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510939A (ja
JP7860139B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/018321 external-priority patent/WO2022187231A1/en
Publication of JP2024510939A publication Critical patent/JP2024510939A/ja
Publication of JP2024510939A5 publication Critical patent/JP2024510939A5/ja
Priority to JP2026032708A priority Critical patent/JP2026090557A/ja
Application granted granted Critical
Publication of JP7860139B2 publication Critical patent/JP7860139B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023553301A 2021-03-03 2022-03-01 オレキシン受容体アゴニストとしてのアリールスルホンアミド Active JP7860139B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026032708A JP2026090557A (ja) 2021-03-03 2026-03-02 オレキシン受容体アゴニストとしてのアリールスルホンアミド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163156164P 2021-03-03 2021-03-03
US63/156,164 2021-03-03
PCT/US2022/018321 WO2022187231A1 (en) 2021-03-03 2022-03-01 Arylsulfoxamides as orexin receptor agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026032708A Division JP2026090557A (ja) 2021-03-03 2026-03-02 オレキシン受容体アゴニストとしてのアリールスルホンアミド

Publications (3)

Publication Number Publication Date
JP2024510939A JP2024510939A (ja) 2024-03-12
JP2024510939A5 true JP2024510939A5 (cg-RX-API-DMAC7.html) 2025-03-10
JP7860139B2 JP7860139B2 (ja) 2026-05-15

Family

ID=83154799

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023553301A Active JP7860139B2 (ja) 2021-03-03 2022-03-01 オレキシン受容体アゴニストとしてのアリールスルホンアミド
JP2026032708A Pending JP2026090557A (ja) 2021-03-03 2026-03-02 オレキシン受容体アゴニストとしてのアリールスルホンアミド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026032708A Pending JP2026090557A (ja) 2021-03-03 2026-03-02 オレキシン受容体アゴニストとしてのアリールスルホンアミド

Country Status (8)

Country Link
US (1) US20240174605A1 (cg-RX-API-DMAC7.html)
EP (1) EP4301728A4 (cg-RX-API-DMAC7.html)
JP (2) JP7860139B2 (cg-RX-API-DMAC7.html)
CN (1) CN117015526B (cg-RX-API-DMAC7.html)
AU (1) AU2022229350A1 (cg-RX-API-DMAC7.html)
CA (1) CA3208567A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023009452A (cg-RX-API-DMAC7.html)
WO (1) WO2022187231A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260083444A (ko) 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
JP7833486B2 (ja) 2021-05-26 2026-03-19 アルカーメス,インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258163B2 (en) 2008-06-04 2012-09-04 Board Of Regents, The University Of Texas System Small-molecule agonists for type-2 orexin receptor
SG11201604639YA (en) * 2013-12-12 2016-07-28 Univ Tsukuba Sulfonamide derivative or pharmaceutically acceptable acid addition salt thereof
WO2016133160A1 (ja) * 2015-02-19 2016-08-25 国立大学法人筑波大学 スルホンアミド誘導体またはその薬学的に許容される酸付加塩
CA2989146A1 (en) * 2015-06-12 2016-12-15 Board Of Regents, The University Of Texas System Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof
JP7170996B2 (ja) * 2017-12-12 2022-11-15 国立大学法人 筑波大学 スルホンアミド誘導体またはその薬学的に許容される酸付加塩
WO2019191327A1 (en) * 2018-03-27 2019-10-03 Board Of Regents, The University Of Texas System Ox2r compounds
US11098029B2 (en) 2019-02-13 2021-08-24 Merck Sharp & Dohme Corp. 5-alkyl pyrrolidine orexin receptor agonists

Similar Documents

Publication Publication Date Title
ES2243441T3 (es) Derivados de imidazolio fundidos.
CA2326833C (en) Indolyl-3-glyoxylic acid derivatives with antitumoral activity
WO2001025190A1 (en) Novel diarylamide derivatives and use thereof as medicines
CN119285527A (zh) 色胺前药
JP2022545359A5 (cg-RX-API-DMAC7.html)
CN113831301B (zh) 苯并噻唑类衍生物及其用途
JP4477097B2 (ja) 中枢神経系障害の治療のための(2s)−(4e)−n−メチル−5−[3−(5−イソプロポキシピリジン)イル]−4−ペンテン−2−アミンの多形形態
HUP0303317A2 (hu) Orto, meta-szubsztituált biszarilszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyszerkészítmények
RU2014131014A (ru) Димерные соединения-агонисты рецептора fgf (fgfr), способ их получения и их терапевтическое применение
TW394769B (en) Acylaminoindole derivatives, intermediates for their preparation, and pharmaceutical compositions containing them
TW200846004A (en) Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
JP2023544716A5 (cg-RX-API-DMAC7.html)
CA2568608A1 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
JP2013542267A5 (cg-RX-API-DMAC7.html)
JOP20240217A1 (ar) مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة
JP2024514366A (ja) 可溶性エポキシドヒドロラーゼ阻害剤としてのピペリジン尿素誘導体
ES2222029T3 (es) Derivados de benzofuroxano y su uso en el tratamiento de angina de pecho.
CN101365461B (zh) 舒林酸衍生物、其用途和其制备
JP2005533038A5 (cg-RX-API-DMAC7.html)
TW496737B (en) Improving the tolerability of pharmaceutically active β-amino acids
JP2021523915A5 (cg-RX-API-DMAC7.html)
JP2001520988A (ja) 疾病に関連する、または薬物が引き起こす運動異常症の治療法
JP2007507473A5 (cg-RX-API-DMAC7.html)
HUE027375T2 (en) Phenyl guanidine derivatives
JP2022539804A5 (cg-RX-API-DMAC7.html)